EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

被引:0
|
作者
Gomez-Dominguez, Elena [1 ]
Montero, Jose-Luis [2 ]
Molina, Esther [3 ]
Casado, Marta
Garcia-Buey, Maria Luisa [4 ]
Simon, Miguel Angel [5 ]
Fuentes, Javier [6 ]
Diaz-Gonzalez, Alvaro [7 ]
Berenguer, Marina [8 ]
Conde, Isabel [9 ]
Garrido, Isabel [10 ]
Macedo, Guilherme [10 ]
Jorquera, Francisco [11 ]
Morillas, Rosa Maria [12 ]
Presa, Jose Antonio [13 ]
Rodriguez-Tajes, Sergio [14 ]
Olivas, Ignasi [15 ]
Londono, Maria Carlota [14 ]
Ampuero, Javier [16 ,17 ]
Romero-Gonzalez, Eva [18 ]
Gonzalez-Padilla, Sheila [18 ]
Escudero-Garcia, Desamparados [18 ]
Martin, Jose Manuel Sousa
Gomes, Dario Lorga [19 ]
Santos, Luis
Olveria, Antonio [20 ]
Hernandez-Guerra, Manuel [21 ]
Santos, Manuel A. [22 ]
Carvalho, Armando S. P.
Uriz, Juan
Gutierrez, Maria Luisa [23 ]
Quinones, Marta [23 ]
Perez, Elia [23 ]
Martinez, Javier [24 ]
Albillos, Agustin [25 ,26 ]
Fernandez-Rodriguez, Conrado [23 ,27 ]
机构
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ Reina Sofia, Cordoba, Spain
[3] Complexo Hosp Univ Santiago, Coruna, Spain
[4] Hosp Univ Princesa, Madrid, Spain
[5] Hosp Univ Lozano Blesa, Zaragoza, Spain
[6] Hosp Univ Miguel Servet, Zaragoza, Spain
[7] Hosp Univ Marques Valdecilla, Santander, Spain
[8] Univ Valencia, Hosp Univ La Fe, Valencia, Spain
[9] Hosp Univ Fe, Valencia, Spain
[10] Ctr Hosp Univ S Joao, Porto, Portugal
[11] Complejo Hosp Leon, Leon, Spain
[12] Hosp Germans Trias Pujol, Barcelona, Spain
[13] Ctr Hosp Tras Os Montes E Alto Douro, Vila Real, Portugal
[14] Hosp Clin Barcelona, Barcelona, Spain
[15] Hosp Clin Barcelona, Barcelona, Spain
[16] Virgen Rocio Univ Hosp, Seville, Spain
[17] Inst Biomed Sevilla IBIS, Seville, Spain
[18] Hosp Clin Univ Valencia, Valencia, Spain
[19] Ctr Hosp Univ Coimbra, Coimbra, Portugal
[20] Hosp Univ La Paz, Madrid, Spain
[21] Hosp Univ Canarias, Tenerife, Spain
[22] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[23] Hosp Univ Fdn Alcorcon, Madrid, Spain
[24] Hosp Univ Ramon y Cajal, Madrid, Spain
[25] Ramon y Cajal Inst Hlth Res, Madrid, Spain
[26] Univ Alcala Henares, Madrid, Spain
[27] Univ Rey Juan Carlos, Madrid, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
116
引用
收藏
页码:S116 / S117
页数:2
相关论文
共 50 条
  • [31] Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel Diseases
    Reves, Joana
    Torres, Joana
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 787 - 789
  • [32] REAL-WORLD EXPERIENCE WITH FIBRATES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Van Hooff, Maria C.
    De Veer, Rozanne C.
    Werner, Ellen
    Beuers, Ulrich H.
    Drenth, Joost P. H.
    Cuperus, Frans J. C.
    Van Hoek, Bart
    Brouwer, Johannes T.
    Klemt-Kropp, Michael
    Van Meer, Suzanne
    Verdonk, Robert C.
    Flink, Hajo J.
    Vrolijk, Jan M.
    Gevers, Tom J.
    Ponsioen, Cyriel Y.
    Van Rooij, Janne E.
    Kerbert-Dreteler, Marjo J.
    Nicolaas, Jerome Sint
    De Vree, J. Marleen
    Poen, Alexander C.
    Friederich, Philip W.
    Tielemans, Merel M.
    Aktas, Huseyin
    Hotho, Daphne M.
    Wit, Ulrike De
    Kuyvenhoven, Johan P.
    Abraham, Sunje
    Kuiper, Edith M.
    Schmittgens, Stephan
    Alderlieste, Yasser A.
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Erler, Nicole S.
    Van der Meer, Adriaan J.
    HEPATOLOGY, 2023, 78 : S2069 - S2071
  • [33] Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
    Cuker, Adam
    Buckley, Brian
    Mousseau, Marie-Catherine
    Barve, Aditya Anand
    Haenig, Jens
    Bussel, James B.
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2051 - 2058
  • [34] Primary biliary cholangitis-response criteria of first-line treatment and perspectives of second-line therapy
    Steinmann, Silja
    Schramm, Christoph
    INNERE MEDIZIN, 2024, 65 (04): : 340 - 346
  • [35] Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis
    van Hooff, Maria C.
    de Veer, Rozanne C.
    Werner, Ellen
    Beuers, Ulrich
    Drenth, Joost P. H.
    Cuperus, Frans J. C.
    van Hoek, Bart
    Veldt, Bart J.
    Klemt-Kropp, Michael
    van Meer, Suzanne
    Verdonk, Robert C.
    Flink, Hajo J.
    Vrolijk, Jan Maarten
    Gevers, Tom J. G.
    Ponsioen, Cyriel Y.
    van Rooij, Janne
    Kerbert-Dreteler, Marjo J.
    Nicolaas, Jerome Sint
    De Vree, Marleen
    de Vries, Elsemieke S.
    Friederich, Philip W.
    Tielemans, Merel M.
    Aktas, Huseyin
    Hotho, Daphne M.
    de Wit, Ulrike
    Kuyvenhoven, Johan P. H.
    Abraham, Sunje
    Kuiper, Edith M. M.
    Schmittgens, Stephan
    Alderslieste, Yasser A.
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Erler, Nicole S.
    van der Meer, Adriaan J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S309 - S310
  • [36] Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
    Adam Cuker
    Brian Buckley
    Marie-Catherine Mousseau
    Aditya Anand Barve
    Jens Haenig
    James B. Bussel
    Annals of Hematology, 2023, 102 : 2051 - 2058
  • [37] Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study
    Nie, Caiyun
    Xu, Weifeng
    Lv, Huifang
    Gao, Xiaohui
    Li, Guofeng
    Chen, Beibei
    Wang, Jianzheng
    Liu, Yingjun
    Zhao, Jing
    He, Yunduan
    Wang, Saiqi
    Chen, Xiaobing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] Real-World Effectiveness and Safety Profile of Lurbinectedin and Other Second-Line Treatments in Small Cell Lung Cancer
    Ganti, Apar Kishor
    Allan, Victoria
    Prince, Patricia
    Estrin, Adina
    Gautam, Nileesa
    Merola, Dave
    Boccuti, Anne
    Rengarajan, Badri
    Baratta, Cristina
    Li, Wenyan
    Cao, Yanyan
    Poole, Elizabeth M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E50 - E51
  • [39] Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
    Scaravaglio, Miki
    Ronca, Vincenzo
    Carbone, Marco
    Invernizzi, Pietro
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [40] Regorafenib as second-line therapy in patients with advanced hepatocellular carcinoma: Interim results from the multicenter real-world study
    Lu, J.
    Zhu, H.
    Guo, J.
    Teng, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S671 - S671